DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study

Hepatocellular carcinoma (HCC) is one of the high-metastatic types of cancer, and metastasis occurs in one-third of patients with HCC. To maintain the effectiveness of drug compounds on cancer cells and minimize their side effects on normal cells, it is important to use new approaches for overcoming...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemi Yeganeh, Hamid, Heiat, Mohammad, Kieliszek, Marek, Alavian, Seyed Moayed, Rezaie, Ehsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617615/
https://www.ncbi.nlm.nih.gov/pubmed/34822533
http://dx.doi.org/10.3390/toxins13110749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617615/
https://www.ncbi.nlm.nih.gov/pubmed/34822533
http://dx.doi.org/10.3390/toxins13110749

Ejemplares similares